Department of Psychiatry and Behavioral Sciences Archive — Page 3 of 12

Headshot of Mary Pawlikowski smiling, wearing a black blazer over a blue top against a brown studio background.
March 14, 2024

Vanderbilt Psychiatric Hospital President Mary Pawlikowski to retire

Mary Pawlikowski, MA, MEd, PsyDABD, president of Vanderbilt Psychiatric Hospital and Vanderbilt Behavioral Health, will retire at the end of the fiscal year. A search will begin for the hospital’s new executive director.

Close-up of a lit cigarette with glowing ash and smoke rising against a black background.
February 29, 2024

Study targets nicotine craving in schizophrenia

Vanderbilt’s Heather Burrell Ward, MD, has received a five-year, $928,000 grant from the National Institute on Drug Abuse to test whether an externally applied magnetic field can reduce nicotine craving in people with schizophrenia.

Abstract blue-and-teal 3D technology background with glowing computer code, programming syntax, and circuit-like interface graphics layered in perspective.
February 8, 2024

New algorithms show promise for predicting bipolar disorder risk

In a new study across three major U.S. health care systems, researchers developed and tested algorithms to predict who will develop bipolar disorder.

Paul Newhouse, MD, smiling in a white medical coat with a stethoscope and striped tie in a hospital corridor.
October 25, 2023

Vanderbilt Center for Cognitive Medicine named Alzheimer’s Clinical Trials Consortium Member Site

The Vanderbilt Center for Cognitive Medicine has been named an Alzheimer’s Clinical Trials Consortium Member Site.

Dark side-profile silhouette of a human head against a blue background, with a dense tangle of white looping lines inside the upper head.
October 19, 2023

VUMC co-hosts the 2023 Mid-South Addiction Conference Oct. 27 and 28

The second-annual 2023 Mid-South Addiction Conference is Oct. 27 and 28 at Vanderbilt University Medical Center.

July 19, 2023

Study highlights consequences of chronic benzodiazepine use

The lived experience of colleagues who took benzodiazepines and experienced distressing effects inspired a recent study that found the depressant is linked to nervous system injury and negative life effects during and after use.